CBUS.US Cibus Global LLC

Healthcare Biotechnology USA Stocks
1.13 USD
Close of Nov 13, 2026
1.02 4.19
Market cap
USD 86.4M
P/E
-
P/B
5.58x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is CBUS.US undervalued?

Graham number

The Graham number of Cibus Global LLC cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cibus Global LLC fundamental analysis

No fundamental analysis for Cibus Global LLC yet.

Cibus Global LLC stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cibus Global LLC

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The co…

Full company profile